A 43-year-old woman was admitted to the hospital for anticoagulation following a pulmonary embolism. She was found to have a deep venous thrombosis on further workup after a long plane ride coming back from visiting China. She denies any personal history of blood clots in her past, but she says that her mother has also had to be treated for pulmonary embolism in the recent past. Her past medical history is significant for preeclampsia, hypertension, polycystic ovarian syndrome, and hypercholesterolemia. She currently smokes 1 pack of cigarettes per day, drinks a glass of wine per day, and she currently denies any illicit drug use. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, heart rate 111/min, and respiratory rate 23/min. On physical examination, her pulses are bounding and complexion is pale, but breath sounds remain clear. Oxygen saturation was initially 81% on room air, with a new oxygen requirement of 8 L by face mask. On day 6 of combined heparin and warfarin anticoagulation, her platelet count decreases from 182,000/mcL to 63,000/mcL. Her international normalized ratio (INR) is not yet therapeutic. What is the next best step in therapy?
AContinue heparin and warfarin until INR is therapeutic for 24 hours
BDiscontinue heparin and warfarin
CContinue heparin and warfarin, and administer vitamin K
DDiscontinue heparin; continue warfarin
EContinue heparin; discontinue warfarin
A 66-year-old man with coronary artery disease and hypertension comes to the emergency department because of intermittent retrosternal chest pain, lightheadedness, and palpitations. He has smoked one pack of cigarettes daily for 39 years. His pulse is 140/min and irregularly irregular, respirations are 20/min, and blood pressure is 108/60 mm Hg. An ECG shows an irregular, narrow-complex tachycardia with absent P waves. A drug with which of the following mechanisms of action is most likely to be effective in the long-term prevention of embolic stroke in this patient?
AIrreversible inhibition of cyclooxygenase
BInterference with carboxylation of glutamate residues
CBinding and activation of antithrombin III
DIrreversible blockade of adenosine diphosphate receptors
EActivation of the conversion of plasminogen to plasmin
A 21-year-old woman comes to the physician because of a 1-day history of right leg pain. The pain is worse while walking and improves when resting. Eight months ago, she was diagnosed with a pulmonary embolism and was started on warfarin. Anticoagulant therapy was discontinued two months ago. Her mother had systemic lupus erythematosus. On examination, her right calf is diffusely erythematous, swollen, and tender. Cardiopulmonary examination shows no abnormalities. On duplex ultrasonography, the right popliteal vein is not compressible. Laboratory studies show an elevated serum level of D-dimer and insensitivity to activated protein C. Further evaluation of this patient is most likely to show which of the following?
ADeficiency of protein C
BProtein S deficiency
CElevated coagulation factor VIII levels
DMutation of coagulation factor V
EMutation of prothrombin
+ 7 more in the PDF
Browse all chapters